Stocks DAKT Financial statements
Financial statementsDAKTRONICS INC /SD/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DAKTRONICS INC /SD/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 587 | 611 | 570 | 609 | 482 | 611 | 754 | 818 | 756 | 839 |
| Cost of revenue | 446 | 465 | 439 | 470 | 361 | 494 | 603 | 596 | 561 | 610 |
| Gross profit | 140 | 146 | 130 | 139 | 121 | 117 | 151 | 222 | 195 | 229 |
| Research and development | 29.1 | 35.5 | 35.6 | 37.8 | 26.8 | 29 | 30 | 35.7 | 38.9 | 43.5 |
| General and administrative | 34.2 | 34.9 | 34.8 | 35.2 | 28 | 32.6 | 38.7 | 42.6 | 63.5 | 59.9 |
| Operating expenses | 125 | 133 | 135 | 139 | 103 | 113 | 130 | 135 | 162 | 168 |
| Operating income | 15.4 | 12.5 | -4.73 | -0.17 | 17.1 | 4.05 | 21.4 | 87.1 | 33.1 | 60.8 |
| Interest expense | 0.23 | 0.22 | 0.16 | 0.11 | 0.3 | 0.05 | 1.13 | 3.4 | 2.87 | 1.46 |
| Interest income | 0.22 | 0.21 | 1.53 | 5.83 | 6.06 | |||||
| Other non-operating income | -0.35 | -0.54 | -1.09 | -0.54 | -2.98 | -3.11 | -7.21 | -13.1 | -17.8 | -6.14 |
| Pre-tax income | 15.6 | 12.4 | -4.94 | -0.01 | 14.1 | 1.11 | 13.3 | 54.1 | -5.85 | 58.3 |
| Income tax | 5.25 | 6.87 | -3.99 | -0.5 | 3.13 | 0.52 | 6.46 | 19.4 | 4.27 | 13 |
| Net income | 10.3 | 5.56 | -0.96 | 0.49 | 10.9 | 0.59 | 6.8 | 34.6 | -10.1 | 45.4 |
| EBITDA | 34 | 30.2 | 13.9 | 17.6 | 34.2 | 19.4 | 38.4 | 106 | 52.7 | 80.2 |
| EPS, basic | 0.23 | 0.13 | -0.02 | 0.01 | 0.24 | 0.01 | 0.15 | 0.75 | -0.21 | 0.93 |
| EPS, diluted | 0.23 | 0.12 | -0.02 | 0.01 | 0.24 | 0.01 | 0.15 | 0.74 | -0.21 | 0.92 |
| Shares, basic (weighted) | 44.1 | 44.5 | 44.9 | 45 | 45 | 45.2 | 45.4 | 45.9 | 47.6 | 48.6 |
| Shares, diluted (weighted) | 44.3 | 44.9 | 44.9 | 45.3 | 45.2 | 45.3 | 45.5 | 46.5 | 47.6 | 49.4 |
| Dividend per share | 0.31 | 0.28 | 0.28 | 0.20 |
Balance sheet
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 32.6 | 29.7 | 35.4 | 40.4 | 77.6 | 17.1 | 24 | 81.3 | 128 | 132 |
| Short-term investments | 1.23 | 0 | 4.02 | 0.53 | 0 | |||||
| Receivables | 78.8 | 77.4 | 65.5 | 72.6 | 67.8 | 101 | 110 | 117 | 92.8 | 119 |
| Inventory | 66.5 | 75.3 | 78.8 | 86.8 | 74.4 | 134 | 149 | 138 | 106 | 110 |
| Other current assets | 7.55 | 9.03 | 8.32 | 9.63 | 7.45 | 15 | 9.68 | 8.53 | 8.52 | 11.3 |
| Total current assets | 258 | 264 | 254 | 252 | 265 | 318 | 343 | 402 | 381 | 448 |
| Property, plant and equipment | 66.7 | 68.1 | 65.3 | 67.5 | 58.7 | 66.8 | 72.1 | 71.8 | 73.9 | 64.3 |
| Goodwill | 7.81 | 8.26 | 7.89 | 7.74 | 8.41 | 7.93 | 3.24 | 3.23 | 3.19 | 3.69 |
| Intangible assets | 4.71 | 3.68 | 4.91 | 3.35 | 2.08 | 1.47 | 1.14 | 0.84 | 0.57 | 3.26 |
| Total assets | 355 | 359 | 349 | 373 | 375 | 441 | 468 | 528 | 503 | 554 |
| Accounts payable | 51.5 | 48.8 | 44.9 | 47.8 | 40.3 | 76.3 | 67.5 | 60.8 | 46.7 | 68.6 |
| Accrued liabilities | 25 | 28.5 | 32.1 | 36.6 | 30.7 | 35 | 36 | 43 | 41.7 | 44.9 |
| Deferred revenue | 12.1 | 39.4 | 47.2 | 50.9 | 64.5 | 90.4 | 91.5 | 65.5 | 69.1 | 65.3 |
| Short-term debt | 0 | 1.5 | 1.5 | 1.15 | ||||||
| Total current liabilities | 131 | 131 | 134 | 146 | 147 | 214 | 210 | 192 | 172 | 194 |
| Long-term debt | 17.8 | 53.2 | 10.5 | 9.63 | ||||||
| Other non-current liabilities | 2.85 | 2.29 | 1.34 | 22.1 | 7.82 | 7.08 | 5.71 | 5.76 | 6.84 | 5.29 |
| Total liabilities | 157 | 161 | 162 | 196 | 182 | 249 | 267 | 289 | 231 | 254 |
| Total debt | 17.8 | 54.7 | 12 | 10.8 | ||||||
| Paid-in capital | 38 | 40.3 | 42.6 | 44.6 | 46.6 | 48.4 | 50.3 | 118 | 190 | 197 |
| Retained earnings | 114 | 107 | 93.6 | 85.1 | 96 | 96.6 | 103 | 138 | 128 | 173 |
| Treasury stock | -1.83 | -1.83 | -1.83 | -7.47 | -7.3 | -10.3 | -10.3 | -10.3 | -39.8 | -65.3 |
| Other comprehensive income | -4.38 | -2.71 | -4.36 | -5.28 | -2.34 | -4.93 | -5.53 | -6.53 | -6.16 | -4.05 |
| Shareholders' equity | 198 | 198 | 188 | 177 | 194 | 192 | 201 | 239 | 272 | 301 |
| Total equity | 198 | 198 | 188 | 177 | 194 | 192 | 201 | 239 | 272 | 301 |
| Total liabilities and equity | 355 | 359 | 349 | 373 | 375 | 441 | 468 | 528 | 503 | 554 |
Cash flow statement
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 10.3 | 5.56 | -0.96 | 0.49 | 10.9 | 0.59 | 6.8 | 34.6 | -10.1 | 45.4 |
| Depreciation and amortization | 18.6 | 17.8 | 18.6 | 17.7 | 17.1 | 15.4 | 17 | 19.3 | 19.5 | 19.3 |
| Stock-based compensation | 2.91 | 2.64 | 2.48 | 2.27 | 2.07 | 1.97 | 2.03 | 2.09 | 2.94 | 4.91 |
| Deferred income tax | -2.04 | 3.15 | -3.38 | -2.18 | 1.31 | -1.56 | -3.63 | -9.07 | -6.3 | 9.94 |
| Change in receivables | -2.72 | 2.27 | 10.9 | -7.46 | 4.86 | -33.9 | -10.4 | -7.73 | 25.2 | -26 |
| Change in inventory | 3.58 | -8.52 | -4.08 | -8.35 | 13.9 | -61.2 | -15.1 | 10.9 | 32.5 | -3.42 |
| Change in payables | 5.54 | -2.57 | -2.75 | 2.38 | -7.08 | 33 | -5.34 | -7.12 | -14.1 | 28.7 |
| Cash from operations | 39.4 | 30.4 | 29.5 | 10.8 | 66.2 | -27 | 15 | 63.2 | 97.7 | 49.2 |
| Capital expenditures | -8.5 | -18.1 | -17.3 | -18.1 | -7.89 | -20.4 | -25.4 | -17 | -19.5 | -14.9 |
| Acquisitions | 0 | 0 | -2.25 | 0 | 0 | |||||
| Purchases of investments | -24.2 | -17.4 | -25.3 | 0 | 0 | -4.05 | 0 | 0 | ||
| Sales and maturities of investments | 15.9 | 15.3 | 33.7 | 25.2 | 1.23 | 0 | 3.49 | 0.55 | 0 | 0 |
| Cash from investing | -18.2 | -19.6 | -11.8 | -4.27 | -10.2 | -31.4 | -25.4 | -21.3 | -23.8 | -19.6 |
| Debt issued | 0 | 0 | 1.23 | 0 | 0 | |||||
| Debt repaid | -0.92 | -1.05 | -0.45 | -2.15 | -0.46 | -0.2 | -0.31 | -0.41 | -0.41 | -0.1 |
| Stock issued | 0.34 | 0.52 | 1.32 | 0 | 0 | 0.01 | 0.02 | 1.3 | 5.15 | 1.8 |
| Share buybacks | -1.83 | 0 | 0 | -5.64 | 0 | -3.18 | 0 | 0 | -29.5 | -25.6 |
| Dividends paid | -13.7 | -12.4 | -12.6 | -8.99 | 0 | 0 | ||||
| Cash from financing | -16.3 | -13.3 | -11.9 | -1.98 | -15.6 | -3.58 | 17.6 | 15.1 | -27.4 | -26.2 |
| Exchange rate effect | -0.59 | -0.62 | 0.22 | 0.11 | -0.42 | -0.4 | -0.52 | -0.07 | -0.65 | 0.79 |
| Net change in cash | 4.31 | -3.08 | 5.99 | 4.67 | 40 | -62.4 | 6.68 | 57 | 45.8 | 4.13 |
| Free cash flow | 30.9 | 12.2 | 12.3 | -7.28 | 58.3 | -47.4 | -10.4 | 46.3 | 78.2 | 34.3 |
| Interest paid | 0.23 | 0.19 | 0.18 | 0.05 | 0.26 | 0.02 | 1.08 | 2.86 | 3.07 | 0.85 |
| Income taxes paid | 3.2 | 8.94 | -1.93 | 0.98 | 2.56 | 1.95 | 7.49 | 26.5 | 17.8 | 5.12 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 27.6% | Gross profit / revenue. |
| Operating margin | 7.3% | Operating income / revenue. |
| EBITDA margin | 9.6% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 7.2% | Pre-tax income / revenue. |
| Net margin | 5.7% | Net income / revenue. |
| FCF margin | 4.7% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 6.4% | Cash from operations / revenue. |
| Effective tax rate | 21.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 15.2% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 8.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 28.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 5.3% | Research and development expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.7% | Capital expenditures / revenue. |
| D&A / revenue | 2.2% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 10.9% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 3.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 11.7% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 17.1% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 14.8% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 13.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 83.7% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 41.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 28.9% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 52.3% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 27.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 18.6% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income CAGR, 3y | 88.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 32.9% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS CAGR, 3y | 83.0% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 30.8% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -49.6% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 48.5% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -5.8% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -56.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | -10.1% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 10.6% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 14.4% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 9.2% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 10.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 5.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 8.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 3.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 2.8% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 1.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.17x | Current assets / current liabilities. |
| Quick ratio | 1.34x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.67x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.03x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 1.7% | Total debt / total assets. |
| Liabilities / assets | 47.7% | Total liabilities / total assets. |
| Net debt | -$144.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | -1.76x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | $270.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 1.1% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $310.8M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.41x | Revenue / average total assets. |
| Fixed asset turnover | 13.3x | Revenue / average property, plant and equipment. |
| Inventory turnover | 5.27x | Cost of revenue / average inventory. |
| Days inventory | 69 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.52x | Revenue / average receivables. |
| Days sales outstanding | 66 days | 365 x average receivables / revenue. |
| Days payables | 47 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 88 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 82.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 27.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.99 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $17.47 | Revenue / diluted weighted shares. |
| FCF per share | $0.81 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.12 | Cash from operations / diluted weighted shares. |
| Book value per share | $6.50 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $6.36 | Tangible book value / shares outstanding. |
| Cash per share | $3.16 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 48.6% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $822.2M | Share price x shares outstanding. |
| Enterprise value | $678.1M | Market cap + total debt - cash - short-term investments. |
| P/E | 17.0x | Market cap / net income. Only when net income is positive. |
| P/S | 0.96x | Market cap / revenue. |
| P/B | 2.59x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 2.65x | Market cap / tangible book value, when positive. |
| P/FCF | 20.7x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 15.1x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.79x | Enterprise value / revenue. |
| EV/EBIT | 10.8x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 8.30x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 17.0x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 4.8% | Free cash flow / market cap. |
| Earnings yield | 5.9% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 2.4% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.20x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was DAKTRONICS INC /SD/'s revenue in fiscal 2026?
DAKTRONICS INC /SD/ reported revenue of $838.7M for fiscal 2026, 10.9% higher than the year before.
Was DAKTRONICS INC /SD/ profitable in fiscal 2026?
Yes. Net income was $45.4M, a net margin of 5.4%.
How much free cash flow did DAKTRONICS INC /SD/ generate in fiscal 2026?
Cash from operations of $49.2M minus capital expenditures of $14.9M left free cash flow of $34.3M.